RE:“The proposed investor day” I find this to be quite strange. TH has clearly signalled they are a cancer stock now. They are partnering in NASH. So, why are they trying to bring everyone together to discuss the second most important thing about the company and one in which they will likely soon relinquish control of? Is it just me or does that seem odd? If you have positioned yourself as largely a cancer stock, how do you not talk about cancer at your R&D Day? You have an R&D Day for NASH only? I am struggling to understand that. Are they hoping to pitch it indirectly to partners via the R&D Day?
Maybe they know they will have announced a partnership by then and want to explain it?
Bucknelly21 wrote: I was told by Philippe that this is a Nash only investor day. Not sure why but that was his response to my question.